Cardinal Health, Inc. (NYSE:CAH) Receives Average Rating of “Hold” from Analysts

Cardinal Health, Inc. (NYSE:CAHGet Free Report) has received an average recommendation of “Hold” from the ten ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $101.38.

Several brokerages have commented on CAH. Barclays began coverage on shares of Cardinal Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. Wells Fargo & Company began coverage on Cardinal Health in a report on Thursday, December 14th. They set an “underweight” rating and a $96.00 price target for the company. JPMorgan Chase & Co. raised their target price on Cardinal Health from $101.00 to $112.00 and gave the company a “neutral” rating in a report on Friday, November 17th. TheStreet downgraded Cardinal Health from a “b-” rating to a “c+” rating in a report on Wednesday, December 27th. Finally, Evercore ISI dropped their price target on Cardinal Health from $100.00 to $95.00 in a research report on Wednesday, October 11th.

Read Our Latest Research Report on Cardinal Health

Insider Activity

In related news, CEO Deborah Weitzman sold 36,642 shares of the business’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $106.31, for a total transaction of $3,895,411.02. Following the transaction, the chief executive officer now directly owns 35,202 shares of the company’s stock, valued at approximately $3,742,324.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.15% of the company’s stock.

Hedge Funds Weigh In On Cardinal Health

Several hedge funds and other institutional investors have recently bought and sold shares of CAH. Panagora Asset Management Inc. increased its holdings in Cardinal Health by 53.6% during the 1st quarter. Panagora Asset Management Inc. now owns 25,616 shares of the company’s stock worth $1,452,000 after purchasing an additional 8,935 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Cardinal Health by 4.8% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 37,071 shares of the company’s stock worth $2,102,000 after purchasing an additional 1,702 shares during the last quarter. Cibc World Market Inc. purchased a new stake in Cardinal Health during the 1st quarter worth approximately $212,000. Blair William & Co. IL increased its holdings in Cardinal Health by 6.7% during the 1st quarter. Blair William & Co. IL now owns 11,769 shares of the company’s stock worth $667,000 after purchasing an additional 734 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in Cardinal Health by 6.4% during the 1st quarter. Sei Investments Co. now owns 472,799 shares of the company’s stock worth $26,792,000 after purchasing an additional 28,568 shares during the last quarter. 86.01% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $104.07 on Wednesday. The firm has a market cap of $25.31 billion, a PE ratio of 40.97, a PEG ratio of 0.92 and a beta of 0.69. Cardinal Health has a one year low of $68.53 and a one year high of $111.40. The firm has a fifty day moving average of $104.51 and a 200 day moving average of $96.95.

Cardinal Health (NYSE:CAHGet Free Report) last released its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm had revenue of $57.45 billion for the quarter, compared to analyst estimates of $57.02 billion. During the same period in the prior year, the firm earned $1.32 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. On average, equities analysts predict that Cardinal Health will post 7.31 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 15th. Shareholders of record on Monday, April 1st will be issued a $0.5006 dividend. This represents a $2.00 annualized dividend and a yield of 1.92%. Cardinal Health’s dividend payout ratio (DPR) is 78.74%.

About Cardinal Health

(Get Free Report

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Read More

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.